|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical relevance of mi- croRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR- 145 in colorectal cancer显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，： | 1 |
| 2 | Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer显示文摘 | Zhai H Fesler A Schee K | 2013 | Clin Colorectal Canc2013，12，4： | 1 |
| 3 | Clinical rele- vance of microRNA miR-21, miR-31, miR-92a, miR- 101, miR-106a and miR-145 in colorectal cancer 显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，： | 1 |
| 4 | Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in coLorectal cancer显示文摘 | Schee K Boye K Abrahamsen T W | 2012 | BMC Cancer2012，12，2： | 1 |
| 5 | Clinical significance of long inter- genic noncoding RNA-p21 in colorectal cancer 显示文摘 | Zhai H Fesler A Schee K | 2013 | Clin Colorectal Cancer2013，12，4： | 1 |
| 6 | Clinical Significance of Long In- tergenic Noncoding RNA-p21 in Colorectal Cancer 显示文摘 | Zhai HY Fesler A Schee K | 2013 | Clinical Col- orectal Cancer2013，12，4： | 1 |
| 7 | Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer显示文摘 | Zhai H Fesler A Schee K | 2013 | Clin Colorectal Cancer2013，12，： | 1 |
| 8 | Clinical significance of long in- tergenic noncoding RNA-p21 in colorectal cancer显示文摘 | Zhai H Fesler A Schee K | 2013 | Clin Color- ectal Cancer2013，12，4： | 1 |
| 9 | Clinical relevance of mi-croRNA miR-21, miR-31, miR-92a, miR-101, miR-l06a and miR-145 in colorectal cancer显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，505： | 1 |
| 10 | Clinical significance g long intergenie noneoding RNA - p21 in colorectal cancer 显示文摘 | Zhai H Fesler A Schee K | 2013 | Clin Colorectal Cancer2013，12，4： | 1 |
| 11 | Clinical relevance if nucriRNA miR-21,miR-31,miR-92a,miR-101,miR-106a and miR-145 in colorectal cancer显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，2： | 1 |
| 12 | Clinical relevance of microR- NA miR-21,miR-31,miR-92a,miR- 101 ,miR- 106a and mir- 145 in colorectal cancer显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，1： | 1 |
| 13 | MicroRNAs as biomarkers in col- orectal cancer显示文摘 | Schee K Fodstad O Flatmark K | 2010 | Am J Pathol2010，177，4： | 1 |
| 14 | Clinical relevance of mi-croRNA miR-21 ,miR-31, miR-92a, miR-101 ,miR-106a and miH-145in colorectal cancer显示文摘 | Schee K Boye K Abrahamsen TW | 2012 | BMC Cancer2012，12，： | 1 |
| 15 | Flatography: Detection of gastrointestinal diseases by faecal gas analysis显示文摘Patients presenting with gastro-intestinal symptoms might suffer from a range of possible underlying diseases. An unmet need exists for novel cost-effective,reproducible, easy-to-perform and non-invasive tests. Hippocrates used body odours to diagnose diseases circa 460 before Christ. The art of diagnostic smelling is making a promising high-tech come-back with portable 'electronic diagnostic noses'. Analysis of faecal volatile organic compounds is a novel field in metabolomics with considerable potential to improve the diagnosis, phenotyping and monitoring of gastro-intestinal disease. Challenges will be to mature over the coming years by development of a standardized methodology for stool sample collection, storage, handling and analysis. Furthermore, key volatiles need to be identified to improve test accuracy and sensitivity by development of sensors tailored toward the accurate identification of disease specific volatiles. If these challenges are adequately faced, analysis of faecal volatiles has realistic potential to considerably improve screening, diagnosis and disease monitoring for gastro-intestinal diseases. | Evelien F de Groot Tim G de Meij Daniel J Berkhout Marc P van der Schee Nanne K de Boer | 2015 | World Journal of Gastrointestinal Pharmacology and Therapeutics2015，6，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员